Finance

Lists
TLX:ASX
Telix Pharmaceuticals Ltd
A$16.34
+4.28%
(+0.67) 1D
Sep 14, 4:13:17 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for TLX...
Open
A$17.50
High
A$17.65
Low
A$15.85
Mkt. cap
5.55B
Avg. vol.
1.70M
Volume
4.72M
P/E ratio
118.42
52-wk high
A$18.32
52-wk low
A$8.26
EPS
A$0.14
Shares outstanding
339.78M
No. of employees
1K
Open
A$17.50
High
A$17.65
Low
A$15.85
Mkt. cap
5.55B
Avg. vol.
1.70M
Volume
4.72M
P/E ratio
118.42
52-wk high
A$18.32
52-wk low
A$8.26
EPS
A$0.14
Shares outstanding
339.78M
No. of employees
1K
News stories
From web sources and news partners
About Telix Pharmaceuticals Ltd
CEOChristian Behrenbruch
Employees1.15K
Founded2015
Headquarters-
SectorBiotechnology
Websitetelixpharma.com
Last report
Jul 20, 2026
Fiscal period
Q2 2026
EPS / Est. (AUD)
- / A$0.03
Revenue / Est. (AUD)
347.45M / 341.96M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
206.72M
206.72M
238.68M
238.68M
Cost of goods sold
110.68M
110.68M
122.86M
122.86M
Cost of revenue
110.68M
110.68M
122.86M
122.86M
Research and development expenses
44.83M
44.83M
61.91M
61.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47.93M
47.93M
53.51M
53.51M
Operating expense
92.02M
92.02M
92.64M
92.64M
Total operating expenses
202.70M
202.70M
215.49M
215.49M
Operating income
4.02M
4.02M
23.18M
23.18M
Other non operating income
-7.23M
-7.23M
-7.45M
-7.45M
EBT including unusual items
-215.00K
-215.00K
14.62M
14.62M
EBT excluding unusual items
-6.75M
-6.75M
13.16M
13.16M
Income tax expense
2.20M
2.20M
-4.54M
-4.54M
Effective tax rate
-1,023.95%
-1,023.95%
-31.05%
-31.05%
Other operating expenses
-745.50K
-745.50K
-22.79M
-22.79M
Net income
-2.42M
-2.42M
19.16M
19.16M
Net profit margin
-1.17%
-1.17%
8.03%
8.03%
Earnings per share
-
-
-
-
Interest and investment income
1.10M
1.10M
1.14M
1.14M
Interest expense
-3.78M
-3.78M
-3.71M
-3.71M
Net interest expenses
-2.68M
-2.68M
-2.57M
-2.57M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.09M
7.09M
28.66M
28.66M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps